Artículos del autor

solaci

Femoropopliteal

FDA Alert on Drug-Coated Balloons and Stents in Femoropopliteal Artery Disease

The US Food and Drug Administration (FDA) has issued an alert on the potential long-term risk of...
solaci -
Coronary disease

Drug eluting Stents vs. Drug Coated Balloons for In-Stent Restenosis

The rationale behind the decision to not add another layer of metal to the artery sounded attractive...
solaci -
Chronic Ischemic cardiopathy

Angiography-Derived FFR: Complicated Software or Imminent Reality?

Angiography-derived fractional flow reserve (FFR) demonstrated substantial usefulness, especially in patients with three-vessel lesions. The functional SYNTAX...
solaci -
Coronary disease

CTO: in Radial Access with Similar Results to Femoral

Courtesy of Dr. Carlos Fava. One of the characteristics of chronic total occlusion (CTO) is the use of...
solaci -
Chronic Ischemic cardiopathy

Asymptomatic Coronary Artery Disease, Silent Ischemia: A Cardiologist’s Headache

We need more evidence to guide us in the management of silent ischemia. Confirmed asymptomatic coronary artery...
solaci -
Coronary disease

Abluminal Sirolimus and luminal CD34 antibody layer: Is COMBO the Future of Stents?

This large cohort of patients treated with the dual therapy COMBO stent has showed excellent outcomes after...
solaci -
Structural heart disease

Cost-Effectiveness of TAVR in Intermediate-Risk Patients

Prior economic analyses had shown that transcatheter aortic valve replacement (TAVR) is cost-effective (which does not mean...
solaci -
Peripheral vascular disease

Pulmonary Artery Denervation Starts to Show Results

Pulmonary artery denervation is associated with significant hemodynamics improvement, as well as improved clinical outcomes in patients...
solaci -